Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Safety and Efficacy Study of Nuc-1031 and Carboplatin Combination to Treat Recurrent Ovarian Cancer (ProGem2)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02303912
Recruitment Status : Completed
First Posted : December 1, 2014
Last Update Posted : May 18, 2021
Information provided by (Responsible Party):
Imperial College Healthcare NHS Trust

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : January 23, 2017
Actual Study Completion Date : January 23, 2017